TOP - Daily

A daily low dose of aspirin could be effective, not just as a preventive measure, but as an additional treatment for those with cancer, according to 3 studies led by Oxford University researchers.

According to Professor Peter Rothwell of the Nuffield Department of Clinical Neurosciences, “What we have now shown is that aspirin also has short-term effects, which are manifest after only 2-3 years.” He continues, “In particular, we show that aspirin reduces the likelihood that cancers will spread to distant organs by about 40-50%.”

The ability to modify chemotherapy treatment could have a major impact on both the physical and psychological well-being of patients. Now, researchers can predict which patients are most likely to suffer serious side effects of chemotherapy, according to a recent study on the effect of genetic variability on the toxicity of chemotherapy in breast cancer.

Nearly 1 in 5 people suffers from chronic pain. Understanding why certain people develop pain while others do not is a major challenge. Achieving individualized therapies effective for specific patient populations is yet another challenge.

The National Cancer Institute (NCI) has reported that the prevalence of glioma, the main type of brain cancer conceived as related to cell phone use, has remained fairly stable, according to US cancer incidence data. According to researchers, cell phone use increased considerably from 1992 to 2008 (from nearly 0% to almost 100% of the population); however, the US trends in glioma incidence did not reflect the rise.

Results of this study were published recently online in the British Medical Journal.

New research shows that many patients taking oral cancer drugs that target key enzymes in tumor cells are also taking other drugs that may inhibit the cancer treatment’s full benefits or increase the risk of side effects.

Although women have demonstrated a greater use of preventive care services, such as colon cancer screening and immunizations, they are failing when it comes to medication management.

There is a great discrepancy among men and women when it comes to how they are prescribed and adhere to their medications. Whereas women use more prescription drugs than men, they are less apt to receive prescription drugs according to clinical guidelines, and they do not comply as well with the medications they are prescribed, according to a new study by Medco Health Solutions, Inc.

By decreasing the cost of drug discovery, a novel invention could potentially allow for increased access to high-quality healthcare and benefit cancer patients receiving personalized chemotherapy treatments. The details were published in a recent issue of the journal Biomaterials.

Treating actinic keratosis, a skin condition that is the most common precursor to sun-related squamous cell carcinoma, can require months with current available therapies. Now, a new topical gel is available by prescription that significantly decreases the amount of treatment time, according to a multicenter phase 3 trial led by researchers at Mount Sinai School of Medicine. The newly approved gel, ingenol mebutate, is applied to the skin for just a few days, making treatment faster and even more effective. Read More ›

Since 1971, the number of cancer survivors in the US has tripled. However, with the achievements in patient survival have come second malignancies and cardiovascular disease among survivors, according to a report by a national scientific committee convened by the National Council on Radiation Protection and Measurements.

The National Comprehensive Cancer Network^® (NCCN^®) has issued new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Adolescent and Young Adult (AYA) Oncology. AYA patients are individuals 15 to 39 years of age at initial cancer diagnosis. The critical issues that AYA patients with cancer and their caregivers encounter at diagnosis, during treatment, and after therapy are addressed in the guidelines.